Diabetes 57:306-314, 2008 DOI: 10.2337/db07-0381 © 2008 by the American Diabetes Association
Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP
1 Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea Address correspondence and reprint requests to Hueng-Sik Choi, PhD, Hormone Research Center, School of Biological Sciences & Technology, Chonnam National University, Gwangju, 500-757, Republic of Korea. E-mail: hsc{at}chonnam.ac.kr
Abbreviations:
ACC, acetyl-CoA carboxylase; Ad-AMPK, adenovirus AMPK; Ad-DN-AMPK, adenovirus dominant negative form of AMPK; Ad-SHP, adenovirus SHP; AICAR, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside; AMPK, AMP-activated protein kinase; CA-AMPK, constitutively active AMPK; DMEM, Dulbecco's modified Eagle's medium; DN-AMPK, dominant negative mutant AMPK; GAPDH, glyceraldehyde-3-phosphate-dehydrogenase; HNF, hepatocyte nuclear factor; LRH-1, liver receptor homolog-1; SF-1, steroidogenic factor-1; SHP, small heterodimer partner
OBJECTIVE—Metformin is an antidiabetic drug commonly used to treat type 2 diabetes. The aim of the study was to determine whether metformin regulates hepatic gluconeogenesis through the orphan nuclear receptor small heterodimer partner (SHP; NR0B2). RESEARCH DESIGN AND METHODS—We assessed the regulation of hepatic SHP gene expression by Northern blot analysis with metformin and adenovirus containing a constitutive active form of AMP-activated protein kinase (AMPK) (Ad-AMPK) and evaluated SHP, PEPCK, and G6Pase promoter activities via transient transfection assays in hepatocytes. Knockdown of SHP using siRNA SHP was conducted to characterize the metformin-induced inhibition of hepatic gluconeogenic gene expression in hepatocytes, and metformin–and adenovirus SHP (Ad-SHP)–mediated hepatic glucose production was measured in B6-Lepob/ob mice.
RESULTS—Hepatic SHP gene expression was induced by metformin, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), and Ad-AMPK. Metformin-induced SHP gene expression was abolished by adenovirus containing the dominant negative form of AMPK (Ad-DN-AMPK), as well as by compound C. Metformin inhibited hepatocyte nuclear factor-4 CONCLUSIONS—We have concluded that metformin inhibits hepatic gluconeogenesis through AMPK-dependent regulation of SHP.
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||